Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Intestinal CART is a regulator of GIP and GLP-1 secretion and expression

Shcherbina, L. LU ; Lindqvist, A. LU ; Thorén Fischer, A. H. LU ; Ahlqvist, E. LU ; Zhang, E. LU ; Falkmer, S. E. ; Renström, E. LU ; Koffert, J. ; Honka, H. and Wierup, N. LU (2018) In Molecular and Cellular Endocrinology 476. p.8-16
Abstract

Impaired incretin effect is a culprit in Type 2 Diabetes. Cocaine- and amphetamine-regulated transcript (CART) is a regulatory peptide controlling pancreatic islet hormone secretion and beta-cell survival. Here we studied the potential expression of CART in enteroendocrine cells and examined the role of CART as a regulator of incretin secretion and expression. CART expression was found in glucose-dependent insulinotropic polypeptide (GIP)-producing K-cells and glucagon-like peptide-1 (GLP-1)-producing L-cells in human duodenum and jejunum and circulating CART levels were increased 60 min after a meal in humans. CART expression was increased by fatty acids and GIP, but unaffected by glucose in GLUTag and STC-1 cells. Exogenous CART had... (More)

Impaired incretin effect is a culprit in Type 2 Diabetes. Cocaine- and amphetamine-regulated transcript (CART) is a regulatory peptide controlling pancreatic islet hormone secretion and beta-cell survival. Here we studied the potential expression of CART in enteroendocrine cells and examined the role of CART as a regulator of incretin secretion and expression. CART expression was found in glucose-dependent insulinotropic polypeptide (GIP)-producing K-cells and glucagon-like peptide-1 (GLP-1)-producing L-cells in human duodenum and jejunum and circulating CART levels were increased 60 min after a meal in humans. CART expression was increased by fatty acids and GIP, but unaffected by glucose in GLUTag and STC-1 cells. Exogenous CART had no effect on GIP and GLP-1 expression and secretion in GLUTag or STC-1 cells, but siRNA-mediated silencing of CART reduced GLP-1 expression and secretion. Furthermore, acute intravenous administration of CART increased GIP and GLP-1 secretion during an oral glucose-tolerance test in mice. We conclude that CART is a novel constituent of human K- and L-cells with stimulatory actions on incretin secretion and that interfering with the CART system may be a therapeutic avenue for T2D.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
CART, Cocaine- and amphetamine-regulated transcript, Enteroendocrine cells, GIP, GLP-1, Incretin hormones
in
Molecular and Cellular Endocrinology
volume
476
pages
8 - 16
publisher
Elsevier
external identifiers
  • scopus:85045472277
  • pmid:29627317
ISSN
0303-7207
DOI
10.1016/j.mce.2018.04.002
language
English
LU publication?
yes
id
47d3f4f6-6e79-4fc2-9060-243759e4788e
date added to LUP
2018-04-24 15:34:51
date last changed
2024-02-13 19:22:30
@article{47d3f4f6-6e79-4fc2-9060-243759e4788e,
  abstract     = {{<p>Impaired incretin effect is a culprit in Type 2 Diabetes. Cocaine- and amphetamine-regulated transcript (CART) is a regulatory peptide controlling pancreatic islet hormone secretion and beta-cell survival. Here we studied the potential expression of CART in enteroendocrine cells and examined the role of CART as a regulator of incretin secretion and expression. CART expression was found in glucose-dependent insulinotropic polypeptide (GIP)-producing K-cells and glucagon-like peptide-1 (GLP-1)-producing L-cells in human duodenum and jejunum and circulating CART levels were increased 60 min after a meal in humans. CART expression was increased by fatty acids and GIP, but unaffected by glucose in GLUTag and STC-1 cells. Exogenous CART had no effect on GIP and GLP-1 expression and secretion in GLUTag or STC-1 cells, but siRNA-mediated silencing of CART reduced GLP-1 expression and secretion. Furthermore, acute intravenous administration of CART increased GIP and GLP-1 secretion during an oral glucose-tolerance test in mice. We conclude that CART is a novel constituent of human K- and L-cells with stimulatory actions on incretin secretion and that interfering with the CART system may be a therapeutic avenue for T2D.</p>}},
  author       = {{Shcherbina, L. and Lindqvist, A. and Thorén Fischer, A. H. and Ahlqvist, E. and Zhang, E. and Falkmer, S. E. and Renström, E. and Koffert, J. and Honka, H. and Wierup, N.}},
  issn         = {{0303-7207}},
  keywords     = {{CART; Cocaine- and amphetamine-regulated transcript; Enteroendocrine cells; GIP; GLP-1; Incretin hormones}},
  language     = {{eng}},
  month        = {{04}},
  pages        = {{8--16}},
  publisher    = {{Elsevier}},
  series       = {{Molecular and Cellular Endocrinology}},
  title        = {{Intestinal CART is a regulator of GIP and GLP-1 secretion and expression}},
  url          = {{http://dx.doi.org/10.1016/j.mce.2018.04.002}},
  doi          = {{10.1016/j.mce.2018.04.002}},
  volume       = {{476}},
  year         = {{2018}},
}